资本实验室2018-05-09 08:00
资本实验室·今日投资关注
聚焦前沿科技创新与传统产业升级
蛋白质工程是生物技术的一个分支,属于合成生物学范畴。
合成生物学从工程学的角度来看待自然界,将细胞设想为可以被设计,并用于执行特定工作的“机器”。
近年来,越来越多的风险资本流入了合成生物学领域。据synb...查看全文
囧尼2014-09-30 13:13
9/30 watchlist: $科恩(CONN)$ $LJPC(LJPC)$ $SUPERCOM LTD NEW(SPCB)$ $Thoratec(THOR)$ $爱恩铁山(IRM)$ $TRAVELCENTERS OF AMERICA LLC(TA)$ $索尼克汽车(SAH)$查看全文
随全球疫情控制形势变化,医疗领域的并购交易亦呈回暖态势。当纳利金融服务集团(NYSE: DFIN)业内当先的资本市场解决方案,臂助全球各个领域的交易项目顺利达成。 2018年,生物科技公司Synthorx借助由DFIN研发的Venue虚拟数据库成功上市(IP... 网页链接
$Synthorx(THOR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001654954-20-001572 Act: 34 Size: 69 KB 网页链接
$Synthorx(THOR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-20-001204 Act: 34 Size: 7 KB 网页链接
$Synthorx(THOR)$ 15-12B Securities registration termination [Section 12(b)] Accession Number: 0001193125-20-022212 Act: 34 Size: 10 KB 网页链接
$Synthorx(THOR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-004929 Size: 16 KB 网页链接
$Synthorx(THOR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-004930 Size: 11 KB 网页链接
$Synthorx(THOR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-004927 Size: 12 KB 网页链接
$Synthorx(THOR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-004928 Size: 7 KB 网页链接
$Synthorx(THOR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-004925 Size: 13 KB 网页链接
$Synthorx(THOR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-004926 Size: 8 KB 网页链接
$Synthorx(THOR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-004923 Size: 7 KB 网页链接